BienRaz Launches Premium D3 + K2 Formula for Bone Health and Heart Function
NEW YORK, April 04, 2026 (GLOBE NEWSWIRE) -- As research continues to…
Accord Healthcare Announces Launch of Denosumab – Second Biosimilar in Bone Health
∇ This medicine is subject to additional monitoring. This will allow quick identification…
Abbott receives regulatory approval for the first denosumab biosimilar in Thailand, expanding access to bone disease treatment
Abbott's denosumab biosimilar is the first approved in Thailand, making advanced therapy for…
